NZM2.MU NOVOZYMES -B-

Other Metals & Mining Munich Exchange
- EUR
Market cap
-
P/E
44.8x
P/B
2.59x
ROE
6.6%
Dividend yield
-
Fundamental score
2.7/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is NZM2.MU undervalued?

Graham number

The Graham number of NOVOZYMES -B- cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NOVOZYMES -B- fundamental analysis

12 of 22 checks passed

ROE 0/2

Low return on equity (6.6%), below 10%.

ROA 1/1

Return on assets (4.5%) is above the industry median (3.2%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (90.9%) is above the 5-year average (-34.1% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (90.9%) is above the industry median (6.0%).

Revenue Growth 2/2

Revenue grew 20.8% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 0/1

Current assets do not cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (25.4%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

No interest expense reported.

PE vs Market 0/1

PE (44.8x) is above the market median (16.6x).

PE vs Industry 0/1

PE (44.8x) is above the industry median (16.6x).

PBV 0/1

Price to book (2.6x) is above the industry median (1.8x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 116.0, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (2.1%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 69.0%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

NOVOZYMES -B- stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NOVOZYMES -B-

There is no Profile data available for NZM2.MU.

Full company profile